First-time Ablation of Atrial Fibrillation Registry

Launched by MEDICAL UNIVERSITY OF WARSAW · Apr 18, 2024

Keywords

ClinConnect Summary

This clinical trial, called the First-time Ablation of Atrial Fibrillation Registry, is studying how to improve the success of a treatment called ablation for people with atrial fibrillation (AF), a common heart rhythm disorder. The researchers want to find out which factors, like health history, heart tests, and even advanced imaging, can help predict whether the ablation will be successful. This is important because although ablation can help manage AF, many patients still experience a return of the condition within the first year after the procedure.

To be eligible for this study, participants should be between the ages of 65 and 74 and have a diagnosis of either paroxysmal (intermittent) or persistent AF. They must also be undergoing their first ablation treatment. However, those who cannot provide informed consent or have serious pre-existing health conditions will not be included. If you join this trial, you can expect to undergo tests and evaluations to help the researchers gather important information that could lead to better treatment options for AF in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • paroxysmal or persistent AF
• • first-time ablation of AF
• Exclusion Criteria:
• • patients unable to give informed consent
• • serious health condition existing before ablation